Physician

Randy Steven Katz, M.D.

According to 2025 Medicare claims, Randy Katz, M.D. (NPI: 1861455529) practices ophthalmology in the West Palm Beach-Boca Raton-Delray Beach, FL market, with the plurality of this provider's patient population coming from Palm Beach, FL. This provider's primary affiliated billing organization is FLORIDA EYE MICROSURGICAL INSTITUTE INC (NPI: 1104971423; TIN: 591675396) and primary practice location at 33426-6319.

Katz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,636 traditional Medicare patients, billed 33,475 HCPCS/CPT codes, and received $5,307,073 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,590 prescription claims across 396 beneficiaries totaling $195,328 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 36 records totaling $27,715. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.7M$5.3M2015 Medicare payment: $4,991,132 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $5,066,299 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,806,291 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $5,066,619 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,702,596 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $4,597,730 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $5,065,803 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,753,327 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,084,451 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,307,073 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,11324,484$4,991,132
20162,09824,798$5,066,299
20172,12523,705$4,806,291
20182,10524,241$5,066,619
20191,95822,426$4,702,596
20201,74620,921$4,597,730
20211,80821,575$5,065,803
20221,75520,415$4,753,327
20231,74327,154$5,084,451
20241,63633,475$5,307,073

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$256K$511K2015 Drug cost: $301,280 (USD; Tot_Drug_Cst)2016 Drug cost: $286,139 (USD; Tot_Drug_Cst)2017 Drug cost: $417,638 (USD; Tot_Drug_Cst)2018 Drug cost: $511,351 (USD; Tot_Drug_Cst)2019 Drug cost: $506,794 (USD; Tot_Drug_Cst)2020 Drug cost: $346,271 (USD; Tot_Drug_Cst)2021 Drug cost: $306,157 (USD; Tot_Drug_Cst)2022 Drug cost: $316,445 (USD; Tot_Drug_Cst)2023 Drug cost: $323,827 (USD; Tot_Drug_Cst)2024 Drug cost: $195,328 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20156352,882$301,280
20165502,258$286,139
20175532,216$417,638
20185582,130$511,351
20194881,903$506,794
20204281,826$346,271
20214041,762$306,157
20224111,767$316,445
20234281,829$323,827
20243961,590$195,328

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye4512,514$106
92014Established patient complete exam of visual system1,2771,813$95
92012Established patient problem focused exam of visual system4841,964$69
92134Imaging of retina1,5703,828$31
92201Extended exam of the back part of the eye with retinal drawing1,1661,571$20

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine633,810$75,149
LumiganBimatoprost542,753$28,688
RhopressaNetarsudil Mesylate281,121$11,415
CombiganBrimonidine Tartrate/Timolol231,540$10,415
ProlensaBromfenac Sodium17823$7,629

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.33$792Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.3$26,923Apellis Pharmaceuticals, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Randy Steven Katz, M.D.?

Tedicare shows public-source Medicare data for Randy Steven Katz, M.D. (NPI 1861455529), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Randy Steven Katz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Randy Steven Katz, M.D.?

Randy Steven Katz, M.D. is linked to FLORIDA EYE MICROSURGICAL INSTITUTE INC (billing NPI 1104971423) in the available physician profile data.

Does Randy Steven Katz, M.D. have Open Payments data?

Randy Steven Katz, M.D. has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.